CD73 promotes cervical cancer growth via EGFR/AKT1 pathway
Cited by 16
Related Papers
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial
|Signal Transduction and Targeted Therapy|2021|66